Science and Health News

Parasitic infection enables helpful bacteria to displace harmful ones in mice and humans

Researchers uncover molecular switch to make effective sugar-responsive, insulin-releasing cells in a dish, offering hope for diabetes therapy

Animal model may help scientists understand molecular, neurological basis of stuttering

Biocad, an innovative developer in St. Petersburg, continues a series of tests for its new breast cancer solution. The drug candidate is expected to show efficacy in fighting the disease at both early and advanced stages.

Lawrence Berkeley National Laboratory (Berkeley Lab) researchers have discovered a new family of nature-inspired polymers that, when placed in water, spontaneously assemble into hollow crystalline nanotubes up to 100 nanometers long with the same diameter.

As part of a global collaboration, scientists from the Icahn School of Medicine at Mount Sinai and Sage Bionetworks conducted the largest genome study to date and reported the first systematic search across hundreds of Mendelian disorders in hundreds of thousands of individuals apparently not afflicted with any of these disorders to identify those carrying disease protective factors. This retrospective study of more than 589,000 genomes was a first step for the Resilience Project and was performed with researchers from 23andMe, BGI, the Ontario Institute for Cancer Research, and other institutions.

Researchers at ETH Zurich have managed to use a synthetic genetic program to instruct stem cells taken from fatty tissue to become cells that are almost identical to natural beta cells. This brings them a major step closer to a personal repair kit for diabetes sufferers.

Stanley Riddell, Fred Hutchinson Cancer Research Center, Seattle, WA Engineering T cells for safe and effective cancer immunotherapy Stanley Riddell, Fred Hutchinson Cancer Research Center